Lin BioScience, Inc. (6696.TWO)
TWD 139.5
(4.1%)
TWD 139.5
(4.1%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 167.73 Million TWD | 44.53% |
| 2022 | 116.05 Million TWD | -75.32% |
| 2021 | 470.25 Million TWD | 52.25% |
| 2020 | 308.87 Million TWD | 191.48% |
| 2019 | 105.96 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 153.96 Million TWD | -8.21% |
| 2024 Q2 | 153.96 Million TWD | 0.0% |
| 2023 Q4 | 167.73 Million TWD | 0.0% |
| 2023 FY | 167.73 Million TWD | 44.53% |
| 2023 Q3 | 167.73 Million TWD | -6.55% |
| 2023 Q2 | 179.47 Million TWD | 0.0% |
| 2023 Q1 | 179.47 Million TWD | 54.65% |
| 2022 FY | 116.05 Million TWD | -75.32% |
| 2022 Q4 | 116.05 Million TWD | 0.0% |
| 2021 FY | 470.25 Million TWD | 52.25% |
| 2020 FY | 308.87 Million TWD | 191.48% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -34.476% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 54.462% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -2003.989% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 48.936% |
| NaviFUS Corp. | 53.4 Million TWD | -214.095% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -39.938% |
| TaiRx, Inc. | 60.62 Million TWD | -176.668% |
| Sinew Pharma Inc. | 39.71 Million TWD | -322.345% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -2434.451% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 26.335% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -2298.198% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 71.254% |
| AP Biosciences Inc | 106.65 Million TWD | -57.271% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 77.117% |
| RBC Bioscience Corporation | 513.08 Million TWD | 67.309% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 82.79% |
| EirGenix Inc. | 1.14 Billion TWD | 85.352% |
| Enimmune corporation | 173.46 Million TWD | 3.305% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -4.142% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -297.86% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -446.69% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 87.368% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 87.324% |
| TCI GENE Inc. | 155.54 Million TWD | -7.832% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -690.21% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 80.641% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -1708.215% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -166.094% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 15.061% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -200.521% |
| Neith Corporation | 17.43 Million TWD | -862.141% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 67.268% |
| VBI | 21.25 Million TWD | -689.281% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 28.0% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 46.533% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -621.264% |
| CHO Pharma, Inc. | 110.83 Million TWD | -51.337% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -188.995% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -557.558% |
| Visgeneer Inc. | 185.6 Million TWD | 9.631% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 53.981% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -49.784% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 65.164% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -21.699% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -78.981% |
| GlycoNex Incorporation | 276.39 Million TWD | 39.316% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 95.249% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 14.419% |
| PharmaEngine, Inc. | 91 Million TWD | -84.307% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 89.131% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 67.409% |
| BiOptic Inc. | 170.56 Million TWD | 1.661% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -51.19% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -263.249% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -158.496% |
| OBI Pharma, Inc. | 650.44 Million TWD | 74.213% |
| Savior Lifetec Corporation | 457.95 Million TWD | 63.374% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -525.555% |
| Level Biotechnology Inc. | 273.2 Million TWD | 38.606% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 92.532% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 57.082% |
| Acepodia, Inc. | 384.47 Million TWD | 56.374% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -96.054% |